Income Statement Beijing Comens New Materials Co.,Ltd.
Equities
300200
CNE1000011V3
Specialty Chemicals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.470 CNY | -0.31% | -4.01% | -26.73% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 930M | 903M | 952M | 998M | 1.03B | |||||
Other Revenues, Total | 30.24M | 57.04M | 148M | 18.04M | 6.56M | |||||
Total Revenues | 960M | 960M | 1.1B | 1.02B | 1.04B | |||||
Cost of Goods Sold, Total | 551M | 564M | 802M | 700M | 760M | |||||
Gross Profit | 409M | 396M | 297M | 316M | 276M | |||||
Selling General & Admin Expenses, Total | 152M | 77.72M | 84.73M | 110M | 113M | |||||
Provision for Bad Debts | -2.88M | 9.75M | -3.36M | 1.22M | 2.49M | |||||
R&D Expenses | 54.76M | 52.75M | 63.56M | 58.99M | 75.44M | |||||
Other Operating Expenses | 9.48M | 8.31M | 7.13M | 8.45M | 5.31M | |||||
Other Operating Expenses, Total | 213M | 149M | 152M | 178M | 196M | |||||
Operating Income | 196M | 247M | 145M | 138M | 79.73M | |||||
Interest Expense, Total | -182K | -149K | -558K | -564K | -191K | |||||
Interest And Investment Income | 15.28M | 21.49M | 28.34M | 13.69M | 25.45M | |||||
Net Interest Expenses | 15.1M | 21.35M | 27.78M | 13.13M | 25.26M | |||||
Currency Exchange Gains (Loss) | -649K | -3.95M | -950K | 2.16M | 540K | |||||
Other Non Operating Income (Expenses) | -127K | -249K | -369K | -373K | -1.5M | |||||
EBT, Excl. Unusual Items | 210M | 264M | 172M | 153M | 104M | |||||
Impairment of Goodwill | - | - | - | - | -453M | |||||
Gain (Loss) On Sale Of Investments | 445K | 933K | 6.41M | -3.03M | 1.64M | |||||
Gain (Loss) On Sale Of Assets | 36.55K | 72.75K | -391K | 442K | -57.77K | |||||
Asset Writedown | -924K | -2.79M | -1.51M | -8.55K | -2.2M | |||||
Legal Settlements | - | - | - | - | -1.9M | |||||
Other Unusual Items | 3.38M | 3.69M | 3.23M | 10.83M | 8.64M | |||||
EBT, Incl. Unusual Items | 213M | 266M | 179M | 161M | -343M | |||||
Income Tax Expense | 27.38M | 33.57M | 20.13M | 22.93M | 7.15M | |||||
Earnings From Continuing Operations | 186M | 233M | 159M | 138M | -350M | |||||
Net Income to Company | 186M | 233M | 159M | 138M | -350M | |||||
Minority Interest | - | - | - | 2.96M | 4.75M | |||||
Net Income - (IS) | 186M | 233M | 159M | 141M | -345M | |||||
Net Income to Common Incl Extra Items | 186M | 233M | 159M | 141M | -345M | |||||
Net Income to Common Excl. Extra Items | 186M | 233M | 159M | 141M | -345M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.44 | 0.55 | 0.37 | 0.33 | -0.8 | |||||
Basic EPS - Continuing Operations | 0.44 | 0.55 | 0.37 | 0.33 | -0.8 | |||||
Basic Weighted Average Shares Outstanding | 425M | 423M | 430M | 427M | 432M | |||||
Net EPS - Diluted | 0.44 | 0.55 | 0.37 | 0.32 | -0.8 | |||||
Diluted EPS - Continuing Operations | 0.44 | 0.55 | 0.37 | 0.32 | -0.8 | |||||
Diluted Weighted Average Shares Outstanding | 425M | 423M | 430M | 440M | 432M | |||||
Normalized Basic EPS | 0.31 | 0.39 | 0.25 | 0.23 | 0.16 | |||||
Normalized Diluted EPS | 0.31 | 0.39 | 0.25 | 0.22 | 0.16 | |||||
Dividend Per Share | 0.25 | 0.3 | 0.15 | 0.15 | - | |||||
Payout Ratio | 30.12 | 46.14 | 80.77 | 45.69 | -18.75 | |||||
Supplemental Items | ||||||||||
EBITDA | 222M | 270M | 169M | 162M | 110M | |||||
EBITA | 198M | 248M | 146M | 139M | 80.81M | |||||
EBIT | 196M | 247M | 145M | 138M | 79.73M | |||||
EBITDAR | 223M | 271M | 170M | 163M | 111M | |||||
Total Revenues (As Reported) | 960M | 960M | 1.1B | 1.02B | 1.04B | |||||
Effective Tax Rate - (Ratio) | 12.84 | 12.61 | 11.22 | 14.27 | -2.09 | |||||
Total Current Taxes | 33.7M | 34.05M | 17.19M | 18.73M | 5.9M | |||||
Total Deferred Taxes | -6.63M | 39.42K | 2.75M | 4.2M | 1.25M | |||||
Normalized Net Income | 131M | 165M | 107M | 98.27M | 69.77M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 522K | 480K | 382K | 388K | 1.28M | |||||
Selling and Marketing Expenses | 73.17M | 34.54M | 39.02M | 50.32M | 65.82M | |||||
General and Administrative Expenses | 77.68M | 43.18M | 45.71M | 59.2M | 46.77M | |||||
Research And Development Expense From Footnotes | 56.17M | 52.84M | 63.8M | 59.21M | 75.61M | |||||
Net Rental Expense, Total | 724K | 724K | 724K | 724K | 1.04M | |||||
Imputed Operating Lease Interest Expense | - | - | 104K | 146K | 198K | |||||
Imputed Operating Lease Depreciation | - | - | 620K | 578K | 842K | |||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | 5.16M | -722K | |||||
Stock-Based Comp., S&M Exp. (Total) | - | - | 1.73M | 16.66M | 2.33M | |||||
Stock-Based Comp., G&A Exp. (Total) | 8.17M | 2.46M | 3.79M | 23.45M | -6.36M | |||||
Total Stock-Based Compensation | 8.17M | 2.46M | 5.52M | 45.27M | -4.76M |